Oxidation of marine oils during in vitro gastrointestinal digestion with human digestive fluids – Role of oil origin, added tocopherols and lipolytic activity by Tullberg, Cecilia et al.
Oxidation of marine oils during in vitro gastrointestinal
digestion with human digestive fluids – Role of oil origin, added
tocopherols and lipolytic activity
Downloaded from: https://research.chalmers.se, 2019-05-11 18:37 UTC
Citation for the original published paper (version of record):
Tullberg, C., Vegarud, G., Undeland, I. (2019)
Oxidation of marine oils during in vitro gastrointestinal digestion with human digestive fluids
– Role of oil origin, added tocopherols and lipolytic activity
Food Chemistry, 270: 527-537
http://dx.doi.org/10.1016/j.foodchem.2018.07.049
N.B. When citing this work, cite the original published paper.
research.chalmers.se offers the possibility of retrieving research publications produced at Chalmers University of Technology.
It covers all kind of research output: articles, dissertations, conference papers, reports etc. since 2004.
research.chalmers.se is administrated and maintained by Chalmers Library
(article starts on next page)
Contents lists available at ScienceDirect
Food Chemistry
journal homepage: www.elsevier.com/locate/foodchem
Oxidation of marine oils during in vitro gastrointestinal digestion with
human digestive ﬂuids – Role of oil origin, added tocopherols and lipolytic
activity
Cecilia Tullberga,⁎, Gerd Vegarudb, Ingrid Undelanda
a Food and Nutrition Science, Department of Biology and Biological Engineering, Chalmers University of Technology, Göteborg, Sweden
bDepartment of Chemistry, Biotechnology and Food Science, Norwegian University of Life Science, Ås, Norway
A R T I C L E I N F O
Keywords:
Marine oils
Human gastrointestinal enzymes
Rabbit gastric lipase
Lipolysis
Lipase inhibitor
Lipid oxidation
Tocopherol
Aldehydes
A B S T R A C T
The formation of malondialdehyde (MDA), 4-hydroxy-2-hexenal (HHE), 4-hydroxy-2-nonenal (HNE), and 4-oxo-
2-nonenal (ONE) in cod liver-, anchovy-, krill-, and algae oil during in vitro digestion with human gastrointestinal
ﬂuids was investigated. Adding rabbit gastric lipase, lipase inhibitor (orlistat) and tocopherols to cod liver oil,
lipolysis and oxidation was also studied. Among the marine oils, the highest aldehyde levels (18 µM MDA, 3 µM
HHE and 0.2 µM HNE) were detected after digestion of cod liver oil, while the lowest levels were detected in krill
and algae oils. Addition of rabbit gastric lipase signiﬁcantly increased the release of HNE during the digestion.
Orlistat signiﬁcantly reduced lipolysis and MDA formation. Formation of MDA and HHE was delayed by toco-
pherols, the tocopherol mix Covi-ox® T 70 EU being more eﬀective than pure α-tocopherol.
1. Introduction
There is today an increasing interest in marine omega-3, or long-
chain n-3 polyunsaturated fatty acids (LC n-3 PUFA), e.g. due to the
association between intake of marine oil and beneﬁcial eﬀects on car-
diovascular diseases (Delgado-Lista, Perez-Martinez, Lopez-Miranda, &
Perez-Jimenez, 2012). However, concerns have been raised regarding
the instability of marine oils due to the high susceptibility to lipid
oxidation during storage, and the indications that marine oils could
oxidize also during digestion (Hu, 2016). Recent studies have shown
that lipid oxidation can take place under physiological conditions re-
levant for in vitro gastrointestinal (GI) digestion of marine oils
(Kristinova, Storrø, & Rustad, 2013; Larsson, Cavonius, Alminger, &
Undeland, 2012; Larsson, Tullberg, Alminger, Havenaar, & Undeland,
2016; Tullberg et al., 2016).
Marine oils generally contain a high level of LC n-3 PUFA, and the
marine LC n-3 PUFA supplement market is rapidly growing, as is the
fortiﬁcation of other foods with marine LC n-3 PUFA. By far the most
common marine oils used today are whole ﬁsh (body) oil (often from
anchovy) and cod liver oil. The possibility to use alternative marine
oils, such as krill- and microalgae oils (in this article referred to as algae
oil), has incremented the hope of ﬁnding more sustainable substitutes
to the traditional ﬁsh oils (Adarme-Vega, Thomas-Hall, & Schenk,
2014). The content of LC n-3 PUFA is generally fairly similar between
krill-, ﬁsh and cod liver oil, but a majority of the LC n-3 PUFAs in krill
oil are bound to phospholipids (PLs), while LC n-3 PUFAs mainly are
located in the sn-2 position of triglycerides (TG) in cod liver oil and ﬁsh
oil (Schuchardt & Hahn, 2013). Also, 22 and 21% of eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA) have been found to be
present in free form in krill oil (Schuchardt et al., 2011). Oil from the
microalgae Schizochytrium sp. contains a high proportion of DHA
compared to other marine oils, while the situation is reversed for EPA
(Kassis, Gigliotti, Beamer, Tou, & Jaczynski, 2012). A very low level of
the FA in microalgae oil from Schizochytrium sp. were found in other
forms than TG; 0.07 w/w% as glycolipids and 0.8 w/w% as PLs (Yao,
Gerde, Lee, Wang, & Harrata, 2015). The recommended daily intake of
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DHA and EPA is 250mg (Efsa Panel on Dietetic Products and Allergies,
2012), hence the total intake of marine oils to reach this daily level
might vary depending on their inherent EPA and DHA composition.
Another feature that distinguish marine oils from each other is the
naturally occurring antioxidants, krill oil is high e.g. in astaxanthin
(Kassis et al., 2012), while algae oils generally are rich in phenolic
compounds and β-carotene (Lv et al., 2015). Fish oils are normally
enriched with tocopherols, as a way to prevent lipid oxidation.
Marine oils are susceptible to lipid oxidation, a highly complex
chain reaction, generating a wide variety of products, and therefore
being diﬃcult to monitor. The complexity has led to an increasing
demand for quantitative analysis methods, targeting speciﬁc lipid oxi-
dation products (Schaich, 2013). Lipid oxidation e.g. leads to the gen-
eration of reactive α,β-unsaturated aldehydes, such as mal-
ondialdehyde (MDA), 4-hydroxy-trans-2-hexenal (HHE), 4-hydroxy-
trans-2-nonenal (HNE), and 4-oxy-2-nonenal (ONE). MDA is derived
from both n-3 and n-6 PUFAs, and is according to the review by Del Rio,
Stewart, and Pellegrini (2005) found e.g. in cell studies to have carci-
nogenic and genotoxic properties. MDA is furthermore commonly used
as a biomarker for lipid oxidation (Del Rio et al., 2005). Other cytotoxic
and genotoxic aldehydes of interest when studying lipid oxidation in
marine oils are HHE and HNE; HHE is derives from lipid oxidation of n-
3 PUFA (Van Kuijk, Holte, & Dratz, 1990), while HNE is connected to n-
6 PUFA (Pryor & Porter, 1990). Another lipid oxidation product, ONE,
is closely related to HNE, and has been shown to be highly genotoxic
and regiospeciﬁc when interacting with DNA. ONE has an even higher
reactivity compared to HNE (Sayre, Lin, Yuan, Zhu, & Tang, 2006). The
exact formation route of ONE is not yet fully understood, but Lee et al.
have shown that ONE can be derived from 4-hydroperoxy-2-nonenal
(Lee & Blair, 2000), and ONE has also been found to be the major lipid
oxidation product from linoleic acid hydroperoxide (Rindgen,
Nakajima, Wehrli, Xu, & Blair, 1999). The formation of MDA, HHE and
HNE has previously been reported during GI digestion of cod liver oil,
both in a static and in a dynamic in vitro digestion model, where it was
shown that the formation of aldehydes increased with digestion time
(Larsson et al., 2016; Tullberg et al., 2016). ONE has to our knowledge
not previously been studied during digestion, however, this would be of
interest due to its high reactivity and its close relation to HNE.
Due to their slightly diﬀerent compositions, one could assume that
the stability of diﬀerent marine oils might diﬀer. Ryckebosch et al.
(2013) showed that oil from krill and microalgae were less prone to
oxidation compared to e.g. ﬁsh oil during storage. Additionally, Frankel
et al. reported signiﬁcant diﬀerences in storage stability when assessing
ﬁsh and algae oil as crude oils versus as emulsions, and the oils were
found to be more prone to oxidation as emulsions (Frankel, Satué-
Gracia, Meyer, & German, 2002). No study to date has compared the
stability of diﬀerent marine oils during digestion; a process which leads
to natural emulsiﬁcation in the duodenum, as well as subjection to
elevated temperature, peristalsis and lipolysis for several hours. Our
hypothesis was that the two oils naturally enriched in endogenous an-
tioxidants (krill and algae oil) would be more stable also during con-
ditions in the GI tract.
A positive relation between degree of lipolysis and oxidation was
observed by Larsson et al. during in vitro digestion of cod liver oil
(Larsson et al., 2012). To investigate this further, a possible approach
would be to add a lipase inhibitor to reduce lipolytic activity, or to add
extra lipases. One of the lipases that recently has been reported to be
important for human lipolysis is gastric lipase, contributing to 10–25%
of the total lipolysis (N’Goma, Amara, Dridi, Jannin, & Carrière, 2011).
This enzyme has earlier not been included when designing in vitro
model digestions (Kostewicz et al., 2014). Whether additional lipase in
the gastric phase has any impact on lipid oxidation during GI digestion
of oils has not been reported before. This would, however, be expected
due to the known susceptibility of free fatty acids (FFA) to oxidation
(Miyashita and Takagi, 1986).
The increasing evidence that lipid oxidation takes place in the GI
tract arises the question of how to prevent this reaction. Larsson et al.
reported that no eﬀect was seen on lipid oxidation, when adding α-
tocopherol at 1mg/mL to a cod liver oil prior to static in vitro digestion
(Larsson et al., 2012). In another study, a slight decrease in aldehydes
was detected in the gastric phase when ethylenediaminetetraacetic acid
(EDTA; 0.13mM), was added to emulsiﬁed cod liver oil (Larsson et al.,
2016). The addition of diﬀerent antioxidant containing beverages, e.g.
red wine and berry juice to herring oil was found to reduce lipid oxi-
dation during gastric in vitro digestion (Kristinova et al., 2013). Similar
results were seen in vivo in minipigs when including fruits and vege-
tables to oxidized vegetable oil in the diet (Gobert et al., 2014). When
adding the synthetic antioxidant 2,6-di-tert-butyl-hydroxytoluene
(BHT) to cod liver oil (800 ppm), lipid oxidation was shown to be al-
most completely inhibited during in vitro digestion. A slight anti-
oxidative eﬀect was also seen at lower BHT levels (20 ppm) (Nieva-
Echevarría, Goicoechea, & Guillén, 2017b). Results are, however,
lacking where commercially relevant levels of diﬀerent types of toco-
pherols are evaluated as antioxidants under GI-conditions. Tocopherols
are declared as food grade and are commonly used by the marine oil
industry.
In this study, four marine oils were studied for the formation of
speciﬁc lipid oxidation-derived aldehydes during GI digestion, using
human digestive ﬂuids. The oils used were unreﬁned krill- and algae oil,
and reﬁned cod liver oil and anchovy oil; the two latter thus being
stripped from heavy metals and other contaminants. Lipolysis and lipid
oxidation during in vitro gastric and duodenal digestion were in-
vestigated. The eﬀect of adding rabbit gastric lipase (RGL), orlistat and
tocopherol mix Covi-ox® T 70 EU, in addition to pure α-tocopherol to
cod liver oil were also studied. The following target aldehydes were
chosen as markers for lipid oxidation; MDA, HHE, HNE, and ONE.
2. Materials and methods
2.1. Chemicals and enzymes
Proteins and enzymes used as standards in the enzyme activity as-
says (porcine pepsin P6887, trypsin from porcine pancreas T0303,
human haemoglobin (Hb) H7379), ethylenediaminetetraacetic acid
(EDTA) disodium salt dihydrate, ascorbic acid, bovine serum albumin
(BSA), 1,1,3,3-tetraethoxypropane (TEP), orlistat and 2,4-dini-
trophenylhydrazine (DNPH) were all purchased from Sigma-Aldrich
(Schnelldorf, Germany). RGL with an activity of 70 U/mg (according to
the manufacturer) was purchased from Germe (Marseille, France).
Covi-ox® T 70 EU was obtained from BASF (Lyngby, Denmark); con-
taining D-α-tocopherol (92.4 mg/g), D-β-tocopherol (15.2 mg/g), D-δ-
tocopherol (146mg/g) and D-γ-tocopherol (468mg/g), according to
the supplier. HHE, HNE and ONE standards were purchased from
Cayman Chemicals (Ann Arbor, USA). A Milli-Q plus system (Merck
Millipore, Darmstadt, Germany) was used to purify the water used to a
resistivity of 18.2 MΩ·cm. All other chemicals used were of analytical
grade.
2.2. Marine oils
Oils of diﬀerent marine origins were used in the digestions. Reﬁned
whole anchovy oil (peruvian anchoveta, Engraulis ringens) and cod liver
oil (Gadus morhua), without added antioxidants, were supplied by Lýsi
hf (Reykjavík, Iceland). The algae oil was an unreﬁned microalgae oil
(Schizochytrium sp.) called Lifés DHA S35-CO100 and supplied from
DSM (Basel, Switzerland). The unreﬁned krill oil Superba™ Krill Oil
(Aker Biomarine Antarctic AS, Oslo, Norway) was produced from
Antarctic krill (Euphausia superba) and provided by Sanpharm AB
(Gothenburg, Sweden). Fatty acid (FA) pattern and peroxide value (PV)
of the oils were analysed as described in 2.5.1 and 2.8, respectively.
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2.3. Human ﬂuids
Saliva was collected from 6 healthy volunteers at Chalmers
University of Technology, Sweden. The saliva was collected in the
morning prior to breakfast, using sterile straw pipettes for saliva pro-
vided by Kemikalia (Skurup, Sweden). Spontaneous drooling was sti-
mulated by showing pictures of ﬁsh dishes to volunteers during col-
lection. Human gastric ﬂuid (HGF) and human duodenal ﬂuid (HDF)
were aspirated from 6 volunteers, according to Tullberg et al. (2016).
The aspirations were done at Lovisenberg Diakonale Hospital (Oslo,
Norway, November 2015), and the study was conducted with approval
from the Norwegian Regional Ethics Committee (project no 2012/2230,
Biobank no 2012/2210). The Declaration of Helsinki was followed, and
all participants in the study signed up as volunteers with informed
consent. The pH and colour of the individual aspirates were assayed, to
avoid the inclusion of samples were reﬂux of duodenal ﬂuid had oc-
curred. Gastric ﬂuid aspirates were excluded if the colour was yellow
and if pH > 4. Individual aspirates were pooled to eliminate individual
eﬀects as much as possible, and samples were stored at−80 °C. Enzyme
activities of the pooled aspirates were assayed as described in Section
2.4. The pH of HGF was set to pH 6 at collection time to preserve the
human gastric lipase from being degraded by the pepsin (Ville, Carrière,
Renou, & Laugier, 2002).
2.4. Characterization of human digestive ﬂuids
Gastric lipase, trypsin and pancreatic lipase activities were assayed
in triplicates immediately after aspiration, while other parameters, bile-
salt-, calcium ion-, ascorbic acid-, trace metal ion-, and Hb concentra-
tions, were analysed in pooled samples after freezing at −80 °C and
thawing. Salivary α-amylase-, pepsin-, trypsin-, and pancreatic lipase
activity were all assayed in the pooled human enzyme ﬂuids in ac-
cordance with the standardized digestion protocol by Minekus et al.
(2014), and the result from the enzymatic activity measurements can be
found in the Supplementary material (Table S1). A comprehensive
overview of the composition of the human GI ﬂuids can be found in the
Supplementary material (Table S2).
Supplementary data associated with this article can be found, in the
online version, at https://doi.org/10.1016/j.foodchem.2018.07.049.
2.4.1. Gastric lipase activity
Gastric lipase activity was assayed in HGF using a titrimetric pro-
tocol as described by Ville et al. (2002). The assay was performed at pH
6, using tributyrin as substrate. Activity of gastric lipase activity in HGF
was calculated in U/mL.
2.4.2. Bile-salt concentrations
A bile acid kit (DiaSys Diagnostic Systems, Holzheim, Germany) was
used to spectrophotometrically determine the bile-salt concentration in
the HDF at 540 nm, according to the manufacturer’s instructions. The
analysis is based on the combined formation of NADH and the dye
formazan, developed due to the action of the enzyme 3α-hydro-
xysteroid dehydrogenase on bile acids. Taurocholic acid was used as a
standard in this assay, and the result are expressed as mmol bile salt/L.
2.4.3. Calcium ion concentration
Calcium ion concentrations in the human digestive ﬂuids were
measured using a Dionex high pressure liquid chromatography (HPLC)
BioLC system (Thermo Scientiﬁc, Sunnyvale, USA) with a CG14 guard
column, combined with an IonPac CS14 analytical column
(4× 250mm). The BioLC was combined with a CD20 conductivity
detector, a GS50 gradient pump, and a Triathlon autosampler
(SparkHolland, Emmen, the Netherlands). Detection was done ac-
cording to Tullberg et al. (2016).
2.4.4. Ascorbic acid concentration
Ascorbic acid was determined by the method described by
Lykkesfeldt (2007), with minor in-house modiﬁcations. Brieﬂy, HGF
and HDF were centrifuged, diluted 1:1 with meta-phosphoric acid (10%
w/v) and disodium EDTA (2mM), vortexed and stored at−80 °C before
analysis. At the time point for analysis, the samples were diluted 1:1
with Tris (2-carbozyethyl) phosphine (TCEP, 0.312mM) in 1:10 McIl-
vaine buﬀer (0.46M Na2HPO4, 0.27M citric acid, pH 4.5) and 9:10
phosphate buﬀer (50mM, disodium EDTA 20% (w/v), pH 2.8). De-
tection of ascorbic acid was conducted using a Jasco Corporation HPLC
system (Tokyo, Japan), including an autosampler (AS-2057) and a plus
pump (AS-2080), and the system was coupled with Aquasil C18 ana-
lytical column (4.6×150mm, Thermo Scientiﬁc, Sunnyvale, USA).
Following HPLC separation, electrochemical detection was done with a
Decade II system (Antec Leyden, Zoeterwoude, the Netherlands). Data
collection was carried out with the software Jasco Chrom Pass (Jasco
Corporation, Tokyo, Japan).
2.4.5. Trace metal ions
Analysis of trace metal ions (Cu, Ni, Zn, Co, Mn, and Fe) in saliva,
HGF, HDF and orlistat were done as described by Tullberg et al. (2016).
Acidic microwave digestion of samples was followed by separation and
detection using ion chromatography coupled with UV–vis, quantiﬁed
with external standards.
2.4.6. Haemoglobin (Hb)
Hb was analysed in the human ﬂuids using a HemoCue® Plasma/
Low Hb System (HemoCue AB, Ängelholm, Sweden), using microcuv-
ettes and human Hb as external standard. The method is based on
oxidation of Hb, derivatization with azide, and transmission detection
of azidmetHb. The results are expressed as g Hb/L.
2.5. Levels, treatments and characteristics of oils to be digested
The aim was to normalize the amount of intake oil based on the
analyzed total EPA and DHA content of the oils, in order to simulate a
daily EPA and DHA intake of 250mg oil by a human. The amounts of
cod liver, anchovy, krill and algae oils digested in the down-scaled di-
gestion model according to this normalization was 32, 21, 29 and
21mg, respectively. The intake liquid (“meal”) included the oil and
water at approximately a 1:10 ratio, to simulate taking an oil capsule
together with a mouthful of water. To determine the background level
of lipid oxidation products and FFA, digestions with water alone, i.e.,
without any oil, were also included in the experimental setup and re-
ferred to as blanks. When assessing the addition of tocopherols, Covi-
ox® T 70 EU (4.5mg/g oil), and α-tocopherol (4.5 mg/g oil), these were
added to cod liver oil just prior to digestion. The lipase inhibitor orlistat
(1.75 mg/mL oil) was added to cod liver oil in the same way. RGL
(0.68 mg/mL HGF, 48 U RGL/mL HGF) was added to the HGF just prior
to the gastric phase of the digestion model.
2.5.1. Initial peroxide value (PV) of the marine oils
The initial peroxide value (PV) of the marine oils before digestion
was determined in accordance with Undeland, Hultin, and Richards
(2002). In short, 150mg oil was diluted in 5mL CHCl3, then again
diluted 1:10 with CHCl3. CHCl3:MeOH (1:1) was then added to the
samples (1:1.5), followed by addition of an ammonium thiocyanate
solution (1:100) and an Fe(II)chloride solution (1:100), before in-
cubation (24 °C, 20min). PV was then spectrophotometrically de-
termined at 500 nm, quantiﬁed with a standard curve from cumene
hydroperoxide (80%), and reported as mmol/kg oil.
2.5.2. Initial tocopherols in the marine oils
Naturally occurring tocopherols in the marine oils were analysed
according to Larsson, Almgren, and Undeland (2007). Tocopherols
were extracted in MeOH, vortexed, sonicated and centrifuged, and then
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analysed on a HPLC system (Jasco, Easton, USA) with a Luna (3mm
i.d× 150mm, 3 µm) C18 column (Phenomenex, Macclesﬁeld, UK).
Detection was done spectroﬂuorometrically at 295 nm (excitation) and
330 nm (emission) by a Shimadzu RF-551 detector (Kyoto, Japan).
Quantiﬁcation was done towards external standards (α-, γ-, δ) and to-
copherols were reported as mg tocopherol/kg oil.
2.6. In vitro static digestion
In this study, a static 3-step in vitro digestion model with human GI
ﬂuids was used (see Fig. 1). The model was modiﬁed according to the
protocol by Minekus et al. (2014), with a special focus on lipid diges-
tion and lipases in the human digestive ﬂuids. This was done by in-
cluding an additional pH-step during gastric digestion, to better simu-
late buﬀering capacity of lipids during digestion in the human body
(Sams, Paume, Giallo, & Carriere, 2016). All the naturally occurring
enzymes and respective activities (U/mL) of pepsin, lipases, proteases,
amylase were kept and recorded as recommended in the protocol by
Minekus et al. (2014), with the exception of external RGL, which was
added in addition to human gastric juice when studying lipolysis of cod
liver oil. This was decided since the native enzyme activities in the
human digestive ﬂuids were considered more natural than boosting the
GI ﬂuids with additional external enzymes. After each addition of di-
gestive ﬂuid, i.e. at the start of the mouth, stomach and intestinal steps,
samples were ﬂushed with N2 gas (15 s) for oxygen reduction. An
overview of the changes in pH and dilution during the digestion pro-
tocol is presented in Fig. 2. Sampling of digests were done in initial
liquid, after addition of saliva, in the gastric phase (t= 0, 60, and
120min), and in the duodenal phase (t= 0, 45, and 90min); using
individual test tubes for each collection point, to avoid inﬂow of ex-
ternal oxygen during sampling. Tubes with digests were ﬂushed with N2
gas (15 s) and stored in −80 °C immediately after sampling. Digestion
was repeated three times for each test condition.
2.7. Analysis of aldehydes; MDA, HHE, HNE and ONE
MDA, HHE, HNE and ONE were determined by liquid chromato-
graphy/atmospheric pressure chemical ionization–mass spectrometry
(LC/APCI-MS) in the digests, in the undigested crude oil, and in the
digestion blanks. This was done according to Tullberg et al. (2016).
Brieﬂy, the digests were mixed with butylated hydroxytoluene (BHT),
EDTA and HCl, to prevent lipid oxidation during analysis and to pre-
cipitate proteins. Aldehydes were derivatized by DNPH, extracted with
dichloromethane, and dissolved in MeOH before separation and de-
tection by LC/APCI-MS. Quantiﬁcation of aldehydes was made against
standard curves of MDA, HHE, HNE, and ONE treated in the same way
as the samples. Data acquisition for MDA, HHE, HNE and ONE were
done in selected ion monitoring (SIM) modes, collecting ions at 234.0,
293.1, 335.1, and 333.0m/z, and at fragmentor setting 50, 150, 170,
and 170, respectively. Measurements were done in single replicates.
2.8. Lipid extraction, separation of free fatty acids (FFA) and analysis of
fatty acid (FA) pattern
2.8.1. Lipid extraction and separation of free fatty acids (FFA)
Lipids were extracted from intake liquid (“meal”) and digested
samples (mouth, gastric (120min) and duodenal (90min) phase), with
CHCl3-MeOH, as described by Tullberg et al. (2016). Throughout the
whole procedure, samples were covered in aluminium foil and kept on
ice to prevent oxidation. The FA heptadecanoic acid (C17:0), was added
from start to all samples as an internal standard. CHCl3-MeOH, con-
taining 0.05% (w/v) BHT, in ratio 2:1 was used for high-fat samples (fat
content > 6%; initial digestion samples), in ratio 1:1 for medium-fat
content samples (2–6%; samples at end of gastric digestion) samples,
and in ratio 1:2 for low-fat samples (fat content < 2%; samples at end
of duodenal digestion). The BHT-enriched CHCl3-MeOH was added to
the samples in a ratio of 10:1, and after vortexing (10 s), NaCl (0.5%)
was added (1:2.75). The tubes were then again vortexed (10 s) and
centrifuged (3000×g, 6 min). The chloroform phase was collected and
evaporated to dryness (N2 gas, 40 °C). In order to analyse the FA pattern
of the FFA in intake liquid and digests, lipid classes (TG, PL and FFA) of
the extracted lipids were pre-separated on solid phase extraction (SPE)-
columns. Telos NH2 SPE-colons (500mg/6mL; Kinesis, St Neots, UK)
and Mega Bond Elut-NH2 (500mg/6mL; Agilent Technologies, Santa
Clara, USA) were used.
2.8.2. Analysis of total fatty acids (FA) and free fatty acids (FFA)
Total FA was analysed in crude oils, intake liquid and digested oils
using the obtained lipid or FFA extracts from 2.8.1, or the crude oils
Fig. 1. Flow chart of digestion protocol.
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dissolved in CHCl3-MeOH (2:1). Lipid extracts, FFA-extracts and oils
were methylated by the in-house methanolic-HCl transesteriﬁcation as
described by Tullberg et al. (2016), and using 3mL petroleum ether to
extract the total FA. The organic phase was analysed using GC–MS with
the external FA standard mix GLC 463 (Nu-Chek prep, Inc., Elysian,
USA). FA methyl esters were then detected as FAME (mg FAME/g oil).
The overall FA composition of the four oils can be found in Table 1, and
the more comprehensive results from the FA composition analysis can
be found in the Supplementary material (Table S3).
2.9. Calculations and statistics
Results are shown as mean values, and error bars represents stan-
dard deviation in cases where n > 2, and (max−min)/2 where n=2.
Statistical diﬀerences between treatments over the whole digestion
period were determined by mixed model with repeated measurements
after logarithmic transformation of aldehyde data. Time was chosen as
the within-subject factors, MDA, HHE and HNE were chosen as de-
pendent factors, respectively, and condition*time was chosen as the
interaction term in the mixed model. Statistical diﬀerences between
groups in each digestion time point was determined by general linear
model univariate analysis, using Tukey’s HSD as post-hoc test (IBM SPSS
Statistics 19, IBM Corp., New York, USA), again after logarithmic
transformation of data. The general linear model was performed with
the eﬀect of gastric lipase and orlistat in one model, and eﬀect of to-
copherols in another model. Missing replicates (in time t= 0, n= 2, for
digestion blanks, algae-, anchovy-, and krill oil digests; aldehyde ana-
lysis) were replaced with mean values ((max+min)/2) to adjust the
residual degrees of freedom (df) to allow for analysis. A signiﬁcance
level of p < 0.05 was used. Data presented in the ﬁgures is non-
transformed.
3. Results
3.1. Lipid oxidation and lipolysis of marine oils of diﬀerent origin during in
vitro digestion
The results from the analysis of MDA, HHE and HNE are shown in
Fig. 3. Data on ONE did not diﬀer from the digestion blank, hence these
results are not included in the ﬁgure. Signiﬁcant diﬀerences in MDA,
HHE and HNE levels between the digested marine oils and digestion
blanks were observed based on the mixed model with repeated mea-
surements on logarithmic data including the whole digestion time, the
only exception being algae oil digests compared to digestion blank for
HNE. Also the algae oil digests diﬀered signiﬁcantly over time com-
pared to digests with the other marine oils (p < 0.05), both for MDA
and HHE. The MDA levels detected were quite stable throughout the
gastric digestion (Fig. 3a). The exception was the anchovy oil digests,
where increased levels of MDA were seen after 60min digestion time,
being signiﬁcantly diﬀerent from the digestion blank (p= 0.015) and
algae oil (p= 0.03). However, this levelled oﬀ at the end of the gastric
digestion (t= 120min). An overall increase in MDA development was
seen in all oil digests during the course of duodenal digestion, with the
highest levels detected in the cod liver oil digests (t= 90min; 16.6 µM)
(Fig. 3d). Overall, more pronounced diﬀerences between the oils were
seen in the duodenal phase, with the anchovy- and cod liver oil digests
being subjected to signiﬁcantly higher MDA development than the
algae oil and krill oil digests; the latter having equal MDA levels at the
end of digestion.
During gastric digestion (Fig. 3b), the levels of HHE formed were
quite low, with cod liver oil and anchovy oil digests having the highest
levels at the end of digestion. At the end of the gastric digestion, a
signiﬁcant diﬀerence between on the one hand algae- and cod liver oil
digests, and on the other hand algae- and anchovy oil digests (p= 0.03;
p=0.02, respectively) was observed. During duodenal digestion
(Fig. 3e), an overall visual trend of increasing formation of HHE was
shown. Again, the development of HHE in cod liver oil and anchovy oil
digests showed similar pattern, with the highest mean HHE level found
in the cod liver oil digests (2.8 µM; t= 90min). Likewise; the algae oil
and the krill oil digests both had signiﬁcantly lower HHE levels com-
pared to the digests with anchovy oil and cod liver oil (p < 0.05 at
t= 45 and 90min).
No signiﬁcant diﬀerences were detected when comparing the dif-
ferent HNE levels in the marine oil digests (Fig. 3c and 3f). During
duodenal digestion there was a general increase in HNE formation in
digests over time; with the exception of krill oil. Algae-, cod liver- and
anchovy oil digests all contained similar levels of HNE at the end of the
duodenal digestion, t= 90min, with the highest levels detected in the
cod liver oil digests (0.18 µM).
Analysis on HPLC showed that the naturally occurring tocopherols
in the marine oils diﬀered, with the highest total levels detected in
algae- and krill oil, while only α-tocopherols could be detected in the
cod liver- and anchovy oil (Supplementary material, Table S4).
Among the four marine oils, it was seen that krill oil gave rise to the
highest total FFA release (51%) at the end of digestion (t= 210min),
although not signiﬁcantly diﬀerent from the FFA release from the other
oils. The highest levels of free EPA was found in the krill and the an-
chovy oil at the end of digestion. Further, at the end of digestion, 14
times more free DHA was observed in algae oil digests compared to cod
liver oil digests, and 5 times more in algae oil compared to krill and
anchovy oil digests (data not shown).
3.2. Eﬀect of addition of a lipase inhibitor (orlistat) and rabbit gastric lipase
(RGL) on lipolysis and gastrointestinal (GI) oxidation of cod liver oil
The results from the analysis of MDA, HHE and HNE after addition
of orlistat and RGL to cod liver oil are shown in Fig. 4. Data on ONE did
not diﬀer from the digestion blank, hence these results are not included
in the ﬁgure. Signiﬁcant diﬀerences in MDA, HHE and HNE levels be-
tween the cod liver oil digests and digestion blank were observed based
on the mixed model with repeated measurements on logarithmic data
including the whole digestion time, the only exception being that no
signiﬁcant diﬀerence was seen between orlistat addition and digestion
blank for HNE levels. Also the cod liver oil digests with RGL diﬀered
signiﬁcantly over time compared to cod liver oil digests without RGL
(p < 0.05) for HNE.
When studying the addition of orlistat to cod liver oil during gastric
digestion, we observed a peak in MDA formation at t= 60min;
reaching 0.16 µM which was higher, although not signiﬁcantly, com-
pared to the MDA level found in digests with pure cod liver oil at the
same time point. The MDA levels in the gastric digests with orlistat
however decreased again during duodenal digestion (p=0.001, t= 0)
and continued to stay low compared to pure cod liver oil throughout
the duodenal digestion (Fig. 4a and d). When analyzing trace metal ions
in the orlistat powder, no contamination was detected (data not
shown).
For HHE and HNE, no signiﬁcant diﬀerences were seen between
Table 1
Fatty acid composition of marine oils, from analysis of total fatty acid methyl
esters (FAME), mg FAME/g oil, n=3. SFA, saturated fatty acids; MUFA,
monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.
FAME Cod liver oil Anchovy oil Krill oil Algae oil
Sum SFA 166 ± 1.37 247 ± 3.66 192 ± 3.31 222 ± 6.77
Sum MUFA 327 ± 4.46 137 ± 2.47 78 ± 3.2 6.6 ± 0.41
Sum PUFA 242 ± 1.94 377 ± 6.78 256 ± 4.31 619 ± 20.4
Sum LC n-3 PUFAa 192 ± 0.98 298 ± 5.02 190 ± 1.67 503 ± 0.62
Sum LC n-6 PUFAa 11.2 ± 0.44 13.5 ± 0.41 1.4 ± 0.37 109 ± 3.58
C20:5 n3 (EPA) 76.9 ± 0.1 150 ± 2.3 120 ± 1.19 7.7 ± 0.27
C22:6 n3 (DHA) 96.2 ± 0.5 124 ± 2.25 60.6 ± 0.26 484 ± 15.59
a Chain length>C18,> 1 double bond starting in n-3 or n-6 position.
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gastric or duodenal digests with pure cod liver oil and addition of or-
listat (Fig. 4b-c, 4e-f). However some visual trends can be noticed
during duodenal digestion (Fig. 4e-f) such as a delay in the onset of
HHE and HNE formation in cod liver oil digests when adding orlistat.
Addition of RGL to HGF gave a non-signiﬁcant increase in MDA
formation in cod liver oil digests, compared to non-fortiﬁed HGF, at the
beginning of the gastric digestion (t= 0, Fig. 4a). During duodenal
digestion, we observed no diﬀerence in MDA formation with or without
addition of RGL to the cod liver oil digests (Fig. 4d). Also for HHE there
were no apparent diﬀerences with or without the addition of RGL, ex-
cept for the slightly higher HHE levels detected at the end of digestion
with RGL (4.1 µM versus 2.8 µM, Fig. 4b and 4e). The development of
HNE in cod liver oil digests was, however, signiﬁcantly higher when
boosting HGF with addition of RGL during gastric digestion, compared
to non-fortiﬁed HGF (p= 0.0004, 0.009, 0.000001; gastric t= 0, 60,
120min; Fig. 4c). Addition of RGL also gave a non-signiﬁcant increase
in HNE formation during duodenal digestion, compared to non-fortiﬁed
HGF, Fig. 4f.
When evaluating the FFA release as % of total FA, Fig. 5, we ob-
served that the addition of orlistat signiﬁcantly reduced lipolysis of cod
liver oil both in the gastric and duodenal step (p=0.0003,
t= 120min; p=0.000004, t= 210min). RGL had no signiﬁcant eﬀect
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on gastric or duodenal lipolysis (Fig. 5), however the mean % FFA re-
lease based on total FA was approximately 25% higher, although dif-
ference was still non-signiﬁcant, in presence of RGL at the end of the
gastric digestion. Data from the analysis of speciﬁc PUFA release can be
found in the Supplementary material (Fig. S1). From this it can be seen
that similar levels of total n-3 PUFA were released during gastric di-
gestion with and without addition of RGL. However, out of the total n-3
PUFA, although non-signiﬁcant, about 10% more EPA, and 20% more
DHA were released from cod liver oil digested with the non-fortiﬁed
HGF, compared to after RGL addition, at the end of gastric digestion
(t= 120min). Additionally, on average 2.2-times more total n-6 PUFA
was released from cod liver oil with RGL at t= 120min, compared to
without RGL (non-signiﬁcant diﬀerence). Addition of orlistat to cod
liver oil led to 20 times less n-3 PUFA, released at the end of digestion,
compared to pure cod liver oil (p < 0.001). More speciﬁcally, 18.7-
times less EPA and 13.5-times less DHA were released from cod liver oil
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with orlistat at t= 210min, compared to without orlistat.
3.3. Eﬀect of addition of α-tocopherol and Covi-ox® T 70 EU on
gastrointestinal (GI) oxidation and lipolysis of oils
When looking at MDA development in cod liver oil digests with and
without tocopherols added, no signiﬁcant diﬀerence during gastric di-
gestion was shown (Fig. 6a). However, during duodenal digestion there
was a visual trend that MDA formation was inhibited by both α-toco-
pherol and Covi-ox® T 70 EU, the latter being most eﬀective (Fig. 6d).
At the start of duodenal digestion, t= 0min, a signiﬁcant diﬀerence
was seen between pure cod liver oil digests and those with Covi-ox® T
70 EU (0.00002), and α-tocopherol (p= 0.0005) added. At the end of
digestion, a signiﬁcant diﬀerence was also seen between pure cod liver
oil and Covi-ox® T 70 EU-fortiﬁed cod liver oil (t = 90min, p= 0.004);
the MDA levels detected were 3.5, 10.2, and 16.6 µM in digests with
Covi-ox® T 70 EU, α-tocopherol, and without tocopherol, respectively.
For HHE, a reduced development both during gastric and duodenal
digestion was observed, with the strongest eﬀect again seen from Covi-
ox® T 70 EU. The levels detected at the end of gastric digestion were
0.06, 0.12 and 0.18 µM; and after duodenal digestion 0.30, 0.90 and
2.77 µM in digests with Covi-ox® T 70 EU, α-tocopherol, and no toco-
pherol, respectively (Fig. 6b and 6e). A signiﬁcant diﬀerence between
pure cod liver oil digests and those fortiﬁed with Covi-ox® T 70 EU was
seen at the end of duodenal digestion (t= 90min, p= 0.01).
Very low levels of HNE were detected in the gastric phase with
tocopherol addition (Fig. 6c). During duodenal digestion, no signiﬁcant
diﬀerences were seen between the treatments, however slightly less
HNE was developed after Covi-ox® T 70 EU addition to the cod liver oil.
4. Discussion
4.1. Why do marine oils of diﬀerent origin oxidize diﬀerently during in vitro
digestion?
The ﬁndings in this study supports the hypothesis that crude marine
oils (reﬁned cod liver- and anchovy oil, vs. unreﬁned krill and algae oil)
have diﬀerent susceptibility towards lipid oxidation during digestion.
The initial levels of total EPA+DHA diﬀered in the marine oils, with
anchovy oil and algae oil (mainly DHA) containing the highest con-
centrations, followed by krill oil and then cod liver oil. Hence, the di-
gests containing the highest amount of total oil (mg) were those with
cod liver oil, but the oxidation proﬁles for MDA, HHE and HNE for cod
liver oil and anchovy oil were still very similar, limiting the likely
impact from this factor. Krill oil is rich in astaxanthin and PLs (130 ppm
and 40 g/100 g oil, respectively, according to supplier), which both
could act protectively against lipid oxidation (Cui & Decker, 2016),
although the surface active PLs additionally can act pro-oxidatively
(Waraho, McClements, & Decker, 2011) and are sometimes ascribed as
more susceptible to oxidative attack than TG (Love & Pearson, 1971). In
a previous study, feeding rats with krill oil had an inhibiting eﬀect on
oxidative stress and inﬂammation levels (Grimstad et al., 2012), which
indicates that some components in krill oil could have a protective ef-
fect against lipid oxidation. We hypothesize the astaxanthin played a
signiﬁcant protective eﬀect under GI-conditions, however, evidence for
this should be a subject for future studies. Another possibility which
would need to be explored further is that the PLs in the krill oil changed
the oxidation route compared to that taking place in oils rich in TG
(Thomsen et al., 2013). Alternative oxidation products that can form in
PL-rich oils via Schiﬀ base formation are pyrroles (Lu, Nielsen, Baron, &
Jacobsen, 2012) and Strecker aldehydes (Lu, Bruheim, Haugsgjerd, &
Jacobsen, 2014). In turn, algae oil contains high levels of inherent
antioxidants such as polyphenols and tocopherols (Lv et al., 2015),
which could explain the low lipid oxidation development seen in the
algae oil digests. This was conﬁrmed by the analysis of total inherent
tocopherols, which ranked the oils as algae > krill > cod liver >
anchovy oil (Supplementary material, Table S4). Worth noting is that
anchovy and cod liver oils found in the store commonly contain added
antioxidants, e.g. tocopherols, to prevent lipid oxidation from occur-
ring.
The relative amount of PUFA in each meal ranked the four marine
oils as algae > krill > anchovy∼ cod, and normalization towards
EPA and DHA levels ranked them as algae > anchovy > cod > krill.
The individual ranking orders on basis of LC n-3 and n-6 PUFAs did
neither match with the susceptibility of the four oils to HHE and HNE
development. This indicates that the total FA unsaturation degree has a
minor impact on aldehyde formation during GI-conditions. We hy-
pothesize instead that endogenous antioxidants plays an important role
for the formation of MDA, HHE and HNE during static in vitro digestion
of marine oils. Another possibility which would explain that the
ranking order of LC n-3 and n-6 PUFA did not match with the HHE and
HNE development, could be that other oxidation products than those
measured here were formed, especially from krill- and algae oil. The
results from this study are in agreement with what was reported by
Ryckebosch et al. who found that krill oil and algae oil were less sus-
ceptible to lipid oxidation, compared to ﬁsh oil, during 8 weeks of
storage at 37 °C (Ryckebosch et al., 2013).
At 60min gastric digestion, the pH was decreased from 6 to 3,
which could explain an enhancement in lipid oxidation in the digests
with anchovy oil. As described e.g. by Kanner and Lapidot (2001), a low
pH could decrease the protective eﬀect of antioxidants, and hence
promote lipid oxidation. A possible explanation for the decrease in
MDA levels detected in the anchovy oil digests after 120min gastric
digestion is that MDA reacted with e.g. proteins present in the HGF.
During duodenal digestion, the aldehyde formation increased, which is
in line with previous studies on lipid oxidation during digestion of
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marine oils (Kenmogne-Domguia, Moisan, Viau, Genot, & Meynier,
2014; Larsson et al., 2012; Larsson, Tullberg, Alminger, Havenaar, &
Undeland, 2016; Tullberg et al., 2016). An explanation to this could be
changes in the matrix composition with the presence of bile salts and
pancreatic enzymes, which in turn e.g. could inﬂuence the emulsiﬁca-
tion of the oil. The presence of already pre-formed lipid oxidation
products from the gastric phase or the increased stirring rate in the
duodenal digestion phase could also play important roles. Since it is still
unknown what contributes the most to the increasing lipid oxidation
during duodenal digestion compared to the gastric digestion, we believe
that it is important to include both a gastric and a duodenal digestion
step, when studying lipid oxidation during in vitro digestion.
Several of our previous studies (Larsson et al., 2012, 2016) observed
like this study that oxidation of marine oils increased during in vitro
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digestion. However, Larsson et al. also observed that the initial oxida-
tive status of cod liver oil mattered for which ﬁnal levels of lipid oxi-
dation products that developed during in vitro digestion (Larsson et al.,
2012, 2016). PV data from the present oils indeed showed that the cod
liver oil was the most oxidized oil prior to digestion, and the algae oil
the least oxidized oil, while the oxidation status for anchovy- and krill
oil were in between. Being substrates for secondary oxidation product
formation, initial lipid hydroperoxide levels thus could be an additional
factor explaining the results of this study. On the other hand, krill oil
had the highest initial levels of MDA prior to digestion, and these high
initial MDA levels obviously did not boost a fast progression of MDA
during digestion, which again could be explained e.g. by alternative
routes of oxidation in the krill oil.
4.2. Role of lipolytic activity and added tocopherols on lipid oxidation
development during digestion
Nieva-Echevarría, Goicoechea, and Guillén (2017a) investigated the
eﬀect of liquid smoking on lipid oxidation and lipolysis of ﬁsh muscle
during GI in vitro digestion, and saw that lipolysis was not aﬀected,
while smoke could prevent lipid oxidation. To our knowledge, no one
has however previously investigated the direct eﬀect of lipolysis during
digestion on lipid oxidation. The release of FFA from triglycerides is
known to increase lipid oxidation during storage and processing
(Miyashita and Takagi, 1986). FFA have been shown to induce lipid
oxidation by attracting transition metal ions which could act as pro-
oxidants at the oil/water interphase (Waraho et al., 2011), and by
catalyzing the generation of hydroxyl radicals from hydroperoxides
(Miyashita and Takagi, 1986). Furthermore, studies done on ﬁsh muscle
have suggested that hydrolysis of PLs have a protective eﬀect on lipid
oxidation, while hydrolysis of TGs would induce lipid oxidation
(Shewfelt, 1981). Based on this we hypothesized that addition of the
lipase inhibitor orlistat would reduce lipid oxidation during digestion.
Results showed that orlistat inhibited lipolysis and delayed the onset of
duodenal lipid oxidation, which conﬁrms the hypothesis that there is a
link between lipolysis and lipid oxidation during GI-conditions. The
addition of RGL had no major eﬀect on lipid oxidation, with the ex-
ception of HNE formation, which was stimulated. When looking into
the speciﬁc FFA released with versus without RGL, total n-3 PUFA re-
lease was unaﬀected, while, although non-signiﬁcant, approximately 2
times more n-6 PUFA was released with RGL. This could explain the
diﬀerence in formation of HHE and HNE, which originate from n-3
PUFA and n-6 PUFA, respectively. This also further conﬁrms the im-
portance of lipolysis in relation to lipid oxidation, and illustrates the
importance of including relevant lipases; we would recommend re-
searchers working with digestion models and lipid containing matrixes
to include gastric lipase. To our knowledge, there is not yet any com-
mercial human gastric lipase available on the market, however using
gastric lipase of other origin, such as rabbit- or dog gastric lipase, have
been suggested as suitable substitutes (Sams et al., 2016).
The release of DHA from the algae oil was signiﬁcantly higher than
from the other marine oil digests at the end of digestion. This can be
expected, considering the high levels of DHA found in the algae oil from
start. At the end of digestion, algae oil digests also had the highest level
of free n-3 PUFA; 2-times higher compared to krill- and anchovy oil
digests, and 6.5 times higher than cod liver oil digests. However, as
discussed in Section 4.1, the high levels of free n-3 PUFA did not
translate into a high development of HHE in the algae oil digests,
suggesting that the net eﬀect of endogenous antioxidants was larger
than the eﬀect of lipolysis.
When adding tocopherols to the cod liver oil (4.5 mg/g oil) we here
saw that lipid oxidation could be delayed. Based on the fact that ad-
dition of 1mg α-tocopherol/g oil to cod liver oil subjected to static in
vitro digestion previously did not shown any eﬀect on lipid oxidation
(Larsson et al., 2012), there seem to be a dose-response eﬀect from
tocopherols on GI lipid oxidation. This is further strengthened by the
study of Van Hecke et al. (2016), who showed that, lipid oxidation
during digestion of high fat beef was reduced with increasing amounts
of α-tocopherol from 0 to 4.5mg/g (Van Hecke et al., 2016). The ad-
dition of a tocopherol mix was expected to work more eﬃciently
compared to addition of pure α-tocopherol, due to synergistic eﬀects.
Kenmogne Domguia et al. reported that at low levels (< 2 ppm), δ- and
γ-tocopherols were still detectable after static in vitro digestion, while α-
tocopherol quickly was consumed (Kenmogne-Domguia et al., 2014).
Similarly, Ha and Igarashi found that α-tocopherol was more suscep-
tible to oxidation, compared to γ- and δ-tocopherol when added to
methyl linoleate (Ha and Igarashi, 1990). The Covi-ox® T 70 EU con-
tains 14% α-, 2% β-, 60% γ-, and 24% δ-tocopherol, and it is well
known that the homologues of the tocopherols have diﬀerent actions,
explained by diﬀerences in the chemical structure of the homologues.
The active groups, the chromanol ring of the tocopherols, have the
methyl substitutions placed in diﬀerent positions in the diﬀerent
homologues (Muggli, 2012). The antioxidative activity of the diﬀerent
tocopherol isomers has previously been found to be ranked as α- > γ-
> β- > δ-tocopherol (T= 20–60 °C) in lard (Telegdy and Berndorfer,
1968) while they were ranked as δ- > β- > γ- > α-tocopherol in
vegetable oils (rapeseed-, soybean-, corn- and olive oil) (Yoshida,
Hirooka, & Kajimoto, 1991), Seppanen, Song, and Saari Csallany (2010)
described how both the speciﬁc food matrix and the tocopherol con-
centration highly inﬂuences the antioxidative eﬀect, which together
with the other ﬁndings illustrate how the prevention of lipid oxidation
by tocopherols must be carefully optimized for each speciﬁc product
and condition.
5. Conclusion
In this study, the origin of marine oils played an important role in
the formation of lipid oxidation-derived aldehydes during static in vitro
GI digestion. The results showed that krill- and algae oils remained less
oxidized compared to anchovy- and cod liver oils, and that re-
duced level of lipolysis reduced development of lipid oxidation during
the digestion. It should be emphasized that this was measured in krill-
and algae oils with their natural antioxidants preserved, since these oils
were unreﬁned; the reﬁned anchovy- and cod liver oil found in the store
would have e.g. external tocopherols added to them. The addition of an
external lipase, RGL, did not signiﬁcantly increase lipolysis, but it in-
creased the levels of HNE detected during overall GI digestion. The li-
pase inhibitor orlistat showed an inhibitory eﬀect on lipid oxidation
during duodenal digestion. Finally, lipid oxidation during static in vitro
GI digestion could be reduced by the addition of tocopherols at levels
relevant for industrial use. Covi-ox® T 70 EU, which consist of several
tocopherol isomers, was found to be more protective than α-tocopherol.
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